Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-17 to 2025-02-10
Current total value of award: $115345.12
Description: 4567166872!KRYSTEXXA 8 MG/ML VIALML